Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicago Inc MDCGF

Healthcare Biotechnology

Recent & Breaking News (GREY:MDCGF)

Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate

Business Wire May 18, 2021

INSERTING and REPLACING Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate

Business Wire April 23, 2021

Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate

Business Wire April 23, 2021

Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate

Business Wire March 16, 2021

Takashi Nagao Appointed President and Chief Executive Officer of Medicago

Business Wire December 4, 2020

CORRECTING and REPLACING Medicago and GSK Announce Start of Phase 2/3 Clinical Trials of Adjuvanted COVID-19 Vaccine Candidate

Business Wire November 12, 2020

Medicago and GSK Announce Start of Phase 2/3 Clinical Trials of Adjuvanted COVID-19 Vaccine Candidate

Business Wire November 12, 2020

Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate

Business Wire July 14, 2020

Medicago engaged by the Canadian Government to develop Ebola monoclonal antibodies

Canada NewsWire October 29, 2015

Medicago awarded a contract by the U.S. Department of Health and Human Services to explore alternate production methods for Ebola antibodies

Canada NewsWire February 24, 2015

Mitsubishi Tanabe Pharma Completes Acquisiton of Medicago

Canada NewsWire September 18, 2013

Medicago Announces Receipt of Final Court Order and Regulatory Approvals for Arrangement with Mitsubishi Tanabe Pharma

Canada NewsWire September 12, 2013

Medicago Shareholders Approve Arrangement with Mitsubishi Tanabe Pharma Corporation

Canada NewsWire August 29, 2013

Medicago Inc. announces leading independent proxy firms recommend voting in favour of the arrangement with Mitsubishi Tanabe Pharma

Canada NewsWire August 19, 2013

Medicago Announces 2013 Second Quarter Financial Results

Canada NewsWire August 9, 2013

Medicago announces special meeting of shareholders to be held on August 29, 2013 to approve the Transaction with Mitsubishi Tanabe Pharma

Canada NewsWire July 31, 2013

Smallcappower.com Daily Investment Idea: Stocks with Increased Trading Volume Last Week Include Medicago Inc, Global Key Investment Ltd and Neonode Inc

Newsfile July 15, 2013

Stockhouse @ the Bell: Resource stocks take down TSX

Stockhouse Editorial July 12, 2013

Esperanza soars 34% on acquisition news: Canadian market movers

Elizabeth Walters July 12, 2013

Medicago to be acquired by Mitsubishi Tanabe Pharma

Stockhouse Editorial July 12, 2013